Small Cap round-up: Vislink, Source BioScience, Alliance Pharma..........
24th Mar 2010 18:43
New chief executive Duncan Lewis has restructured Vislink's operations so they are based on customer sectors rather than technologies. The core news and entertainment division reported much lower revenues as its major US contract came to an end. The law enforcement division is benefiting from increa
Read moreLondon close: More gains for FTSE 100
6th Jan 2010 16:34
It was another day of gains for the FTSE 100 after the leading share index hauled itself into the blue in afternoon trading. Marks & Spencer was among the stocks dragging Footsie lower and finished firmly in the red. It was not the numbers from the fashion and food retailer that upset the market s
Read moreLondon afternoon: Leading shares mixed
6th Jan 2010 13:50
The list of Footsie constituents is now almost evenly split between risers and fallers but the blue-chip index remains in negative territory, weighed down by Marks & Spencer, which remains out of favour after a disappointing trading update. It was not the numbers from Marks & Spencer that upset th
Read moreLondon midday: No sparks from Marks
6th Jan 2010 11:52
Leading shares were attempting their second rally of the morning as the lunchtime session started, but almost two-thirds of FTSE 100 constituents remain in the red. Chief among them is M&S. The cold weather may have seen woolly jumpers and slippers fly off the shelves at Marks & Spencer in the days
Read moreAlliance Pharma to top forecasts
6th Jan 2010 08:10
Speciality pharmaceutical company Alliance Pharma expects 2009 results will be well ahead of market expectations, though it warned that it may have to take an impairment charge for the value of its Isprelor product. Pre-tax profit, excluding exceptional charges, are expected to equal or exceed £8.5
Read moreSmall caps round-up: Charteris, Hilton, Clarkson...
5th Nov 2009 15:17
Business software specialist Charteris cut its dividend by 60% as it slumped into a loss of £1.2m in the year to July from a profit of £1.35m. Revenue fell to £20.3m (2008: £23.4m). The dividend is 0.2p per share against 0.5p. "Our business experienced challenging trading conditions throughout the
Read moreLondon afternoon: Market in holiday mood
9th Sep 2009 14:22
Footsie made an assault on the 5,000 level over the lunchtime session but fell short, as investors took note of expectations of a flat start on Wall Street. With mergers and acquisition activity back on the agenda British Airways is in demand on hopes of a swift conclusion to its team-up with Spani
Read moreLondon midday: Consumer confidence boost for equities
9th Sep 2009 12:03
After a hesitant start leading shares have turned higher, helped by the August Nationwide Consumer Confidence index which indicated British consumers are more confident than at any time since May last year. Oil and gas explorer BG Group hailed 'excellent' test drilling results from its 30% owned Gu
Read moreAlliance Pharma pays dividends
9th Sep 2009 08:50
Speciality pharmaceutical company Alliance Pharma has started paying dividends after interim profits almost tripled. Profit before tax in the first half of 2009 rose to £2.89m from £1.02m in the first half of 2008. Revenue surged to £13.27m from £9.90m, with growth principally driven by sales of D
Read moreAlliance Pharma half-year sales up 33%
7th Jul 2009 13:26
Shares in Alliance Pharma gained after the medicines supplier said trading has been strong with half year sales up 33% at around £13.2m. There has also been an improvement in average gross margin rates as a result of changes in the sales mix. As a result, pre-tax profits for the half year are now e
Read moreAlliance Pharma trading ahead of expectations
21st May 2009 08:16
Medicines supplier Alliance Pharma said trading in the first four months of 2009 has been ahead of company expectations and significantly ahead of last year. "In particular, revenue from Deltacortril, which is used in the treatment of inflammatory and auto-immune conditions, continues to grow, fol
Read more